Corrigendum to “Modification of TAK1 by O-linked N-acetylglucosamine facilitates TAK1 activation and promotes M1 macrophage polarization” (Cellular Signalling (2016) 11 (1742–1752)(S0898656816302066)(10.1016/j.cellsig.2016.08.008));Modification of TAK1 by O-linked N-acetylglucosamine facilitates TAK1 activation and promotes M1 macrophage polarization

Cellular Signalling

Volumn 28, Issue 11, 2016, Pages 1742-1752

  Zhang, Dongmei ^a,b   Xu, Zhiwei ^a,b   Tao, Tao ^a,b   Liu, Xiaojuan ^a,b   Sun, Xiaolei ^a,b   Ji, Yuhong ^a   Han, Lijian ^b   Qiu, Huiyuan ^b   Zhu, Guizhou ^a   Shen, Yifen ^a   Zhu, Liang ^b   Shen, Aiguo ^b  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Macrophage; O GlcNAcylation; Polarization; TGF activated kinase 1 (TAK1)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; JANUS KINASE; MUTANT PROTEIN; N ACETYLGLUCOSAMINE; SERINE; SODIUM CHLORIDE; THREONINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLCNACYLATION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; NF KAPPAB GENE; NONHUMAN; OSMOTIC STRESS; POLARIZATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION;

EID: 84982263966     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2016.10.008     Document Type: Erratum

References (36)

1. [1] Gordon, S., Martinez, F.O., Alternative activation of macrophages: mechanism and functions. Immunity 32:5 (2010), 593–604.
2. [2] Biswas, S.K., Mantovani, A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11:10 (2010), 889–896.
3. [3] Hayakawa, K., Wang, X., Lo, E.H., CD200 increases alternatively activated macrophages through cAMP-response element binding protein — C/EBP-beta signaling. J. Neurochem. 136:5 (2016), 900–906.
4. [4] Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:12 (2008), 958–969.
5. [5] Ogura, Y., Hindi, S.M., Sato, S., Xiong, G., Akira, S., Kumar, A., TAK1 modulates satellite stem cell homeostasis and skeletal muscle repair. Nat. Commun., 6, 2015, 10123.
6. [6] Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., Matsumoto, K., Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:5244 (1995), 2008–2011.
7. [7] Sylvain-Prevost, S., Ear, T., Simard, F.A., Fortin, C.F., Dubois, C.M., Flamand, N., McDonald, P.P., Activation of TAK1 by chemotactic and growth factors, and its impact on human neutrophil signaling and functional responses. J. Immunol. 195:11 (2015), 5393–5403.
8. [8] Shirakabe, K., Yamaguchi, K., Shibuya, H., Irie, K., Matsuda, S., Moriguchi, T., Gotoh, Y., Matsumoto, K., Nishida, E., TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272:13 (1997), 8141–8144.
9. [9] Swarnkar, G., Karuppaiah, K., Mbalaviele, G., Chen, T.H., Abu-Amer, Y., Osteopetrosis in TAK1-deficient mice owing to defective NF-kappaB and NOTCH signaling. Proc. Natl. Acad. Sci. U. S. A. 112:1 (2015), 154–159.
10. [10] Wells, L., Vosseller, K., Hart, G.W., Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291:5512 (2001), 2376–2378.
11. [11] Muthusamy, S., Hong, K.U., Dassanayaka, S., Hamid, T., Jones, S.P., E2F1 transcription factor regulates O-linked N-acetylglucosamine (O-GlcNAc) transferase and O-GlcNAcase expression. J. Biol. Chem. 290:52 (2015), 31013–31024.
12. [12] Pekkurnaz, G., Trinidad, J.C., Wang, X., Kong, D., Schwarz, T.L., Glucose regulates mitochondrial motility via Milton modification by O-GlcNAc transferase. Cell 158:1 (2014), 54–68.
13. [13] Motoyoshi, S., Yamamoto, Y., Munesue, S., Igawa, H., Harashima, A., Saito, H., Han, D., Watanabe, T., Sato, H., Yamamoto, H., cAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-products. Biochem. J. 463:1 (2014), 75–82.
14. [14] Ge, H., Yuan, W., Liu, J., He, Q., Ding, S., Pu, J., He, B., Functional relevance of protein glycosylation to the pro-inflammatory effects of extracellular matrix metalloproteinase inducer (EMMPRIN) on monocytes/macrophages. PLoS One, 10(2), 2015, e0117463.
15. [15] Butkinaree, C., Park, K., Hart, G.W., O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim. Biophys. Acta 1800:2 (2010), 96–106.
16. [16] Ouyang, C., Nie, L., Gu, M., Wu, A., Han, X., Wang, X., Shao, J., Xia, Z., Transforming growth factor (TGF)-beta-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit alpha (PKACalpha) and X-linked protein kinase (PRKX). J. Biol. Chem. 289:35 (2014), 24226–24237.
17. [17] Xu, Z., Li, X., Chen, J., Zhao, J., Wang, J., Ji, Y., Shen, Y., Han, L., Shi, J., Zhang, D., USP11, deubiquitinating enzyme, associated with neuronal apoptosis following intracerebral hemorrhage. J. Mol. Neurosci. 58:1 (2016), 16–27.
18. [18] Xu, Z., Chen, J., Shi, J., Zhao, J., Wang, J., Ji, Y., Han, L., Zhu, L., Li, X., Zhang, D., Upregulated expression of karyopherin alpha2 is involved in neuronal apoptosis following intracerebral hemorrhage in adult rats. Cell. Mol. Neurobiol. 36:5 (2016), 755–765.
19. [19] Pathak, S., Borodkin, V.S., Albarbarawi, O., Campbell, D.G., Ibrahim, A., van Aalten, D.M., O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release. EMBO J. 31:6 (2012), 1394–1404.
20. [20] Tian, S., Chen, S.Y., Macrophage polarization in kidney diseases. Macrophage, 2(1), 2015.
21. [21] Van Ginderachter, J.A., Meerschaut, S., Liu, Y., Brys, L., De Groeve, K., Hassanzadeh Ghassabeh, G., Raes, G., De Baetselier, P., Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 108:2 (2006), 525–535.
22. [22] Prickett, T.D., Ninomiya-Tsuji, J., Broglie, P., Muratore-Schroeder, T.L., Shabanowitz, J., Hunt, D.F., Brautigan, D.L., TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB. J. Biol. Chem. 283:28 (2008), 19245–19254.
23. [23] Li, L., Chen, Y., Li, J., Yin, H., Guo, X., Doan, J., Molkentin, J.D., Liu, Q., TAK1 regulates myocardial response to pathological stress via NFAT, NFkappaB, and Bnip3 pathways. Sci. Rep., 5, 2015, 16626.
24. [24] Slawson, C., Housley, M.P., Hart, G.W., O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. J. Cell. Biochem. 97:1 (2006), 71–83.
25. [25] Guo, B., Liang, Q., Li, L., Hu, Z., Wu, F., Zhang, P., Ma, Y., Zhao, B., Kovacs, A.L., Zhang, Z., Feng, D., Chen, S., Zhang, H., O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation. Nat. Cell Biol. 16:12 (2014), 1215–1226.
26. [26] Yu, Y., Ge, N., Xie, M., Sun, W., Burlingame, S., Pass, A.K., Nuchtern, J.G., Zhang, D., Fu, S., Schneider, M.D., Fan, J., Yang, J., Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression. J. Biol. Chem. 283:36 (2008), 24497–24505.
27. [27] Sakurai, H., Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol. Sci. 33:10 (2012), 522–530.
28. [28] Singhirunnusorn, P., Suzuki, S., Kawasaki, N., Saiki, I., Sakurai, H., Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J. Biol. Chem. 280:8 (2005), 7359–7368.
29. [29] Gawlowski, T., Suarez, J., Scott, B., Torres-Gonzalez, M., Wang, H., Schwappacher, R., Han, X., Yates, J.R. 3rd, Hoshijima, M., Dillmann, W., Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-beta-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J. Biol. Chem. 287:35 (2012), 30024–30034.
30. [30] Qiu, H., Liu, F., Tao, T., Zhang, D., Liu, X., Zhu, G., Xu, Z., Ni, R., Shen, A., Modification of p27 with O-linked N-acetylglucosamine regulates cell proliferation in hepatocellular carcinoma. Mol. Carcinog., 2016.
31. [31] Li, Y., Cai, L., Wang, H., Wu, P., Gu, W., Chen, Y., Hao, H., Tang, K., Yi, P., Liu, M., Miao, S., Ye, D., Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2. Oncogene 30:36 (2011), 3887–3899.
32. [32] Bashir, S., Sharma, Y., Elahi, A., Khan, F., Macrophage polarization: the link between inflammation and related diseases. Inflamm. Res. 65:1 (2016), 1–11.
33. [33] Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., Dieli, F., Ghisletti, S., Natoli, G., De Baetselier, P., Mantovani, A., Sica, A., Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc. Natl. Acad. Sci. U. S. A. 106:35 (2009), 14978–14983.
34. [34] Li, P., Zhao, Q.L., Jawaid, P., Rehman, M.U., Sakurai, H., Kondo, T., Enhancement of hyperthermia-induced apoptosis by 5Z-7-oxozeaenol, a TAK1 inhibitor, in A549 cells. Cell Stress & Chaperones, 2016.
35. [35] Sai, K., Morioka, S., Takaesu, G., Muthusamy, N., Ghashghaei, H.T., Hanafusa, H., Matsumoto, K., Ninomiya-Tsuji, J., TAK1 determines susceptibility to endoplasmic reticulum stress and leptin resistance in the hypothalamus. J. Cell Sci. 129:9 (2016), 1855–1865.
36. [36] Jang, I., Kim, H.B., Seo, H., Kim, J.Y., Choi, H., Yoo, J.S., Kim, J.W., Cho, J.W., O-GlcNAcylation of eIF2alpha regulates the phospho-eIF2alpha-mediated ER stress response. Biochim. Biophys. Acta 1853:8 (2015), 1860–1869.